zepbound glp-1 As Insurers Struggle With Drug Costs, Some Seek To Wean Patients Off Taking a GLP-1? Doctors say
Description
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease

10.1210/clinem/dgaa894 16 CherneyD

K., Liu, B., Cui, X., & Brown, K
This isn't your typical supplement origin story

regulations and high manufacturing costs significantly drive up prices
